Showing results (651-660 of 747) with videos related to
Sort By:
Pageof 75
Plos Pathogens|October 13, 2018
Concurrent infection with Mycobacterium tuberculosis confers robust protection against secondary infection in macaquesAnthony M Cadena, Forrest F Hopkins, Pauline Maiello, et al.Biomaterials|August 2, 2020
Novel culture system via wirelessly controllable optical stimulation of the FGF signaling pathway for human and pig pluripotencyIn Young Choi, HoTae Lim, Alex Huynh, et al.BMC Research Notes|May 22, 2013
Development of a proof of concept immunochromatographic lateral flow assay for point of care diagnosis of Mycobacterium tuberculosisLiya Wassie, Markos Abebe, Abraham Aseffa, et al.Nature Biotechnology|May 26, 2015
COMPASS identifies T-cell subsets correlated with clinical outcomesLin Lin, Greg Finak, Kevin Ushey, et al.Ebiomedicine|March 18, 2025
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic settingMichele Tameris, Virginie Rozot, Claire Imbratta, et al.Vaccine|March 16, 2010
Ag85B-ESAT-6 adjuvanted with IC31 promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteersJaap T van Dissel, Sandra M Arend, Corine Prins, et al.Plos One|July 27, 2007
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infectionMichaela Lucas, Axel Ulsenheimer, Katja Pfafferot, et al.Vaccine|September 15, 2014
The novel tuberculosis vaccine, AERAS-402, is safe in healthy infants previously vaccinated with BCG, and induces dose-dependent CD4 and CD8T cell responsesBenjamin M N Kagina, Michele D Tameris, Hennie Geldenhuys, et al.American Journal of Respiratory and Critical Care Medicine|January 7, 2017
Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized TrialRichard N van Zyl-Smit, Aliasgar Esmail, Mary E Bateman, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2009
Novel generation mycobacterial adjuvant based on liposome-encapsulated monomycoloyl glycerol from Mycobacterium bovis bacillus Calmette-GuérinClaire A Swetman Andersen, Ida Rosenkrands, Anja W Olsen, et al.Pageof 75